These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35234361)

  • 1. A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Brighton T; Pasalic L
    Int J Lab Hematol; 2022 Jun; 44(3):654-665. PubMed ID: 35234361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonizing factor assay-related testing performed in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Brighton T; Pasalic L
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):402-411. PubMed ID: 35867944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-laboratory assessment of congenital thrombophilia assays performed on the ACL TOP 50 family for harmonisation of thrombophilia testing in a large laboratory network.
    Favaloro EJ; Mohammed S; Vong R; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Brighton T; Pasalic L
    Clin Chem Lab Med; 2021 Sep; 59(10):1709-1718. PubMed ID: 34116591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of the ACL Top 50 Family (350, 550, and 750) for Harmonization of Routine Coagulation Assays in a Large Network of 60 Laboratories.
    Favaloro EJ; Mohammed S; Vong R; McVicker W; Chapman K; Swanepoel P; Kershaw G; Cai N; Just S; Connelly L; Prasad R; Brighton T; Pasalic L
    Am J Clin Pathol; 2021 Sep; 156(4):661-678. PubMed ID: 33891005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
    Moore GW; Foxton E; Platton S; Yartey N; White D; MacDonald SG
    J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
    Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
    Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
    McGlasson DL; Fritsma GA
    Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
    Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
    J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly developed dilute Russell's viper venom reagents for lupus anticoagulant detection with improved specificity.
    Moore GW; Peyrafitte M; Dunois C; Amiral J
    Lupus; 2018 Jan; 27(1):95-104. PubMed ID: 28549386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
    Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
    Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing.
    Cabo J; Morimont L; Baudar J; Guldenpfennig M; Jacqmin H; Soleimani R; Lecompte T; Douxfils J; Mullier F
    Int J Lab Hematol; 2023 Feb; 45(1):126-136. PubMed ID: 36222181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.